Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00034424 · ClinicalTrials.gov registry record
Cause of Familial Testicular Cancer
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 749
- Enrollment target
NCT00034424: Completed study, sponsored by National Cancer Institute (NCI).
NCT00034424 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 749 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00034424 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 749 participants
- Enrollment target
Study Summary
Background: People with a family history of testicular cancer may be at increased risk for the disease. Genetic and clinical studies of patients with testicular cancer and their family members may help clarify the cause of the disease and identify clinical features. Objectives: To characterize the clinical features of testicular cancer. To identify genes that may lead to increased risk of the disease. To examine emotional and behavioral issues of members of families at increased risk of the disease. Eligibility: Males and females from a family with at least two cases of testicular cancer in blood relatives. Males with testicular cancer in both testicles. Males with testicular cancer who have an identical twin. Participants must be at least 12 years of age. Design: Participants may take part in Part 1 or Parts 1 and 2 of this 2-part study. Part 1 participants: * Provide a blood or cheek cell sample to obtain DNA for gene studies. * Provide permission for researchers to obtain their medical records for review. * Complete questionnaires about their personal and family medical history, exposure to factors that might influence the risk of testicular cancer, and their feelings about being a member of a family in which several members have testicular cancer. * These data are collected from participants in their home communities. Part 2 participants: * All participants provide a medical history, have a complete physical examination, including routine lab tests, and have an ultrasound test of the abdomen to look at the kidneys. * Males have an ultrasound test of the testicles and scrotum. * Females have an ultrasound test of the pelvis to look at the ovaries, uterus and fallopian tubes. * Males 18 years of age and older provide a semen sample. * Some participants have computed tomography (CT) scanning of the chest, abdomen and pelvis instead of kidney ultrasound. Children under 18 years of age may have magnetic resonance imaging (MRI) instead of CT. * These
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 749 participants |
| Start Date | 2003-01-13 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00034424
The ClinicalTrials.gov registry entry for NCT00034424 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 749 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00034424 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00034424 about?
NCT00034424 is a clinical study titled "Cause of Familial Testicular Cancer". Background: People with a family history of testicular cancer may be at increased risk for the disease. Genetic and clinical studies of patients with testicular cancer and their family members may help clarify the cause of the disease and identify clinical features. Objectives: To characterize t...
What is the current status of trial NCT00034424?
This trial is currently completed. The enrollment target is 749 participants. The study started on 2003-01-13.
Who is sponsoring clinical trial NCT00034424?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.